Anti-CDK2 Antibody

Targeting Cyclin-Dependent Kinase 2 (CDK2), a serine/threonine kinase central to G1/S cell cycle progression and extensively studied in cancer biology, this affinity-purified polyclonal primary antibody from Antibodies.com is raised in rabbit and supplied as an unconjugated IgG reagent in a 100 µl volume. It is validated for Western blot detection of the endogenous ~33 kDa CDK2 protein and shows reactivity with Human, Mouse, and Rat samples, enabling comparative studies across mammalian cell lines and tissue lysates. Common research uses include profiling CDK2 expression in synchronized cell populations, monitoring post-translational regulation, and probing tumor-derived material for activity-linked changes. Because the antibody is unconjugated, laboratories can pair it with HRP- or fluorophore-conjugated secondary antibodies for chemiluminescent or fluorescent WB workflows. For long-term performance, storage at -20 °C in small working aliquots is recommended and freeze-thaw cycles should be limited.